Chilling Complications: A Case of Cryoglobulinemic Vasculitis in a Patient With Newly Diagnosed Sjögren’s Syndrome
Open Access
- 23 March 2026
- journal article
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Abstract
In rare circumstances, Sjögren’s syndrome can cause systemic illness in the form of cryoglobulinemic vasculitis (CV). Diagnostic workup is of the utmost importance to prevent severe end-organ damage and even death, especially in the case of rapidly progressive disease. In this case, a 47-year-old male presented to the hospital with shortness of breath, unilateral leg swelling, and a lower extremity wound worsening over a three-month period. During this admission, the patient was found to have diffuse lymphadenopathy with a negative workup for malignancy. The patient met the criteria for Sjögren’s syndrome and was initiated on outpatient disease-modifying antirheumatic drug (DMARD) therapy. The patient was readmitted to the hospital in undifferentiated shock and was found to have CV, with significant end-organ damage. He was treated with pulse-dose steroids, plasmapheresis, and rituximab infusions. After a lengthy three-month admission, he was finally discharged in stable condition. CV can present very similarly to antiphospholipid syndrome and antineutrophil cytoplasmic antibody (ANCA) vasculitis. Biopsies prove invaluable in the diagnosis. This manifestation of Sjögren’s syndrome is uncommon, and it is often difficult to assess which patients may be more at risk for the complication. This case illustrates the importance of early identification of patients with Sjögren’s syndrome who may be at risk for the development of vasculitis.Keywords
This publication has 11 references indexed in Scilit:
- AB0850 RITUXIMAB IN CRYOGLOBULINEMIC VASCULITIS SECONDARY TO PRIMARY SJÖGREN’S SYNDROME: THE EARLIER THE BETTER. A SINGLE-CENTER RETROSPECTIVE COHORT STUDYAnnals of the Rheumatic Diseases, 2024
- Cryoglobulinaemic vasculitis diagnostic and treatment recommendationsRheumatology, 2021
- Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with RituximabInternal Medicine, 2021
- Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related diseaseSeminars in Arthritis and Rheumatism, 2020
- ANCA-Associated Vasculitis: Core Curriculum 2020American Journal of Kidney Diseases, 2020
- The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive reviewJournal of Autoimmunity, 2018
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitisArthritis & Rheumatism, 2011
- Preliminary classification criteria for the cryoglobulinaemic vasculitisAnnals of the Rheumatic Diseases, 2011
- Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV‐related cryoglobulinemiaJournal of Clinical Apheresis, 2009
- Cryoglobulinemia in autoimmune rheumatic diseases: Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndromeArthritis & Rheumatism, 1986